Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fulcrum Therapeutics Inc
(NQ:
FULC
)
7.795
-0.455 (-5.52%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Fulcrum Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 16, 2023
Via
Benzinga
$3.4 Million Bet On CrowdStrike Holdings? Check Out These 3 Stocks Insiders Are Buying
January 09, 2023
Although US stocks closed sharply higher on Friday, there were a few notable insider trades.
Via
Benzinga
Over $13 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying
December 19, 2022
Although US stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
Looking Into Fulcrum Therapeutics's Return On Capital Employed
December 06, 2022
Via
Benzinga
Fulcrum Therapeutics Earnings Preview
November 07, 2022
Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Fulcrum...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 19, 2022
Gainers ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million.
Via
Benzinga
Recap: Fulcrum Therapeutics Q2 Earnings
August 11, 2022
Fulcrum Therapeutics (NASDAQ:FULC) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
4 Analysts Have This to Say About Fulcrum Therapeutics
June 13, 2022
Within the last quarter, Fulcrum Therapeutics (NASDAQ:FULC) has observed the following analyst ratings:
Via
Benzinga
Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday
October 21, 2022
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million...
Via
Benzinga
U.S. Stock Futures Edge Lower Ahead Of Walmart, Home Depot Earnings
August 16, 2022
Pre-open movers
Via
Benzinga
Analyst Ratings for Fulcrum Therapeutics
May 17, 2022
Within the last quarter, Fulcrum Therapeutics (NASDAQ:FULC) has observed the following analyst ratings:
Via
Benzinga
Recap: Fulcrum Therapeutics Q1 Earnings
May 09, 2022
Fulcrum Therapeutics (NASDAQ:FULC) reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session
October 20, 2022
Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment.
Via
Benzinga
Walmart, Home Depot And 3 Stocks To Watch Heading Into Tuesday
August 16, 2022
With US stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Fulcrum Therapeutics Earnings Preview
August 10, 2022
Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 12, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 11, 2022
Via
Benzinga
10 Biggest Price Target Changes For Monday
June 13, 2022
RBC Capital reduced Tesla, Inc. (NASDAQ: TSLA) price target from $1,175 to $1,100. Tesla shares fell 3.7% to $670.89 in pre-market trading.
Via
Benzinga
Mid-Afternoon Market Update: Dow Drops Over 600 Points; Fulcrum Therapeutics Shares Tumble
June 10, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 600 points on Friday.
Via
Benzinga
91 Biggest Movers From Friday
June 13, 2022
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 10, 2022
Via
Benzinga
Mid-Day Market Update: Nasdaq Dips 400 Points; Cogent Biosciences Shares Jump
June 10, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite tumbling around 400 points on Friday.
Via
Benzinga
44 Stocks Moving In Friday's Mid-Day Session
June 10, 2022
Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower; US Inflation Rate Accelerates to 8.6%
June 10, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 600 points on Friday.
Via
Benzinga
Looking Into Fulcrum Therapeutics's Return On Capital Employed
June 03, 2022
Benzinga Pro data, Fulcrum Therapeutics (NASDAQ:FULC) reported Q1 sales of $2.59 million. Earnings fell to a loss of $25.93 million, resulting in a 10.41% decrease from last quarter.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 01, 2022
On Wednesday, 73 stocks hit new 52-week lows.
Via
Benzinga
Earnings Preview: Fulcrum Therapeutics
May 06, 2022
Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Fulcrum...
Via
Benzinga
Fulcrum Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know
May 04, 2022
Fulcrum Therapeutics (NASDAQ:FULC) will host a conference call at 08:00 AM ET on May 9, 2022, to discuss Q1 2022 earnings results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 13, 2022
Gainers
Via
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.